doxazosin has been researched along with Acute Confusional Senile Dementia in 1 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coelho, BP | 1 |
| Gaelzer, MM | 1 |
| Dos Santos Petry, F | 1 |
| Hoppe, JB | 1 |
| Trindade, VMT | 1 |
| Salbego, CG | 1 |
| Guma, FTCR | 1 |
1 other study available for doxazosin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's Disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Alzheimer Disease; Animals; Antineoplastic Agents; Cell Lin | 2019 |